The Directorate General of Civil Aviation (DGCA) has moved to tighten drug-testing rules for India’s commercial pilots following an Air India captain’s positive test for a psychoactive substance after a Phuket–Delhi flight incident. The regulator is directing airlines to ensure a one-time screening of all pilots, with the exercise to be completed by July 2027, against the existing requirement of randomly testing at least 10% of flight crew each year.
The move follows growing concern over pilot fitness and aviation safety after Air India flight AI2379 suddenly gained and then lost altitude on August 4, injuring 24 people. The Aircraft Accident Investigation Bureau (AAIB) has since called the confirmed use of a psychoactive substance by the pilot-in-command a “serious concern”. Air India has terminated the pilot and has already ordered one-time screening across its group, covering more than 5,000 pilots.
DGCA Tightens Checks
The regulatory push comes after the captain of Air India’s Phuket–Delhi flight was found “non-negative” for a psychoactive substance in a confirmatory test following the August 4 incident. The Airbus A320, flying at around 36,000 feet, experienced a temporary loss of all three hydraulic systems, causing the autopilot to disengage and triggering a brief stall warning.
The aircraft first climbed about 113 metres before dropping roughly 89 metres, with 20 passengers and four crew members reported injured in the preliminary investigation. The AAIB has recommended that the DGCA take action to prevent substance abuse among pilots.
Air India said the pilot was “terminated with immediate effect”, citing its “zero-tolerance approach to violation of safety, fitness or regulatory requirements”. The airline had already gone beyond the existing DGCA rules by beginning mandatory screening of all pilots across Air India and Air India Express in August. The company said the initiative was intended to uphold safety and professionalism and reassure passengers and other stakeholders.
From Random Testing To Wider Screening
Under the existing DGCA framework, introduced in 2021 and effective from January 2022, airlines must randomly test at least 10% of their relevant flight crew each year. The rules cover substances including cannabis, cocaine, opiates, amphetamine-type stimulants, barbiturates and benzodiazepines. Testing is also required in certain circumstances following safety-related incidents.
The latest move reflects a broader debate over whether testing should become more comprehensive and frequent. Civil Aviation Minister K Rammohan Naidu had earlier said the DGCA was consulting airlines, pilot organisations and other stakeholders on strengthening the system. He said the government’s view was that every pilot should undergo testing at a random time during the year, rather than limiting checks to 10% of the pilot network. The Federation of Indian Pilots has also called for oral-fluid testing to complement existing methods and proposed increasing random testing to 20–25%.
The Logical Indian’s Perspective
Aviation safety depends not only on sophisticated aircraft and technology but also on a culture where responsibility, transparency and fitness for duty are non-negotiable. Stronger screening can help protect passengers and pilots alike, but it should be implemented fairly, with clear safeguards around prescribed medicines, confidentiality and rehabilitation where appropriate.
A long-term policy must also distinguish between genuine safety risks and isolated, medically explainable results. Testing procedures should be scientifically robust, independently monitored and supported by timely confirmatory tests and transparent appeals.
Airlines should provide confidential counselling and rehabilitation programmes, while regulators must ensure that no pilot is unfairly penalised because of legitimate medication or an administrative error. At the same time, deliberate violations must invite firm consequences. A consistent national framework could prevent uneven enforcement across airlines and reassure passengers that safety standards are applied equally.
The Air India case also underlines why regulators, airlines and pilot representatives must work together rather than respond only after an incident. Safety should ultimately be about prevention, accountability and restoring public trust, not simply punishment. As India’s aviation sector grows, do you think universal pilot drug screening should become a permanent annual requirement?
Also Read: LPG Refill Booking Gap Cut From 45 Days To 25 Days
